摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3-cyanophenyl)-2-cyanopyrimidine | 145276-24-0

中文名称
——
中文别名
——
英文名称
4-(3-cyanophenyl)-2-cyanopyrimidine
英文别名
2-cyano-4-(3-cyanophenyl)-pyrimidine;4-(3-cyanophenyl)pyrimidine-2-carbonitrile
4-(3-cyanophenyl)-2-cyanopyrimidine化学式
CAS
145276-24-0
化学式
C12H6N4
mdl
——
分子量
206.206
InChiKey
YHWHFPFTPKWUDK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    456.8±47.0 °C(Predicted)
  • 密度:
    1.32±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    73.4
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    S-Adenosylmethionine decarboxylase inhibitors: new aryl and heteroaryl analogs of methylglyoxal bis(guanylhydrazone)
    摘要:
    A series of 3-acylbenzamidine (amidino)hydrazones 7a-h, the corresponding (hetero)aromatic congeners 7i-p, and 3,3'-bis-amidino-biaryls 25a-e were synthesized. The hydrazones 7a-p were prepared by conversion of the corresponding acyl nitriles 1a,c-di,n-p to the imido esters 3a,c-d,i and the amidines 5a,c-d,h-i, followed by a reaction with aminoguanidine, or vice versa. Similarly, the biaryl 3,3'-dinitriles 23a-e were converted, via the imino esters 24a-c or the imino thioesters 27d-e, to the diamidines 25a-e. These new products are conformationally constrained analogues of methylglyoxal bis(guanylhydrazone)(MGBG). They are up to 100 times more potent as inhibitors of rat liver S-adenosylmethionine decarboxylase (SAMDC) and generally low potent inhibitors of rat small intestine diamine oxidase (DAO) than MGBG. Some of these SAMDC inhibitors, eg., compounds 7a, 7e, 7i, 25a, and 25d, have shown antiproliferative effects against T24 human bladder carcinoma cells. These products, whose structure-activity relationships are discussed, are of interest as potential anticancer agents and drugs for the treatment of protozoal and Pneumocystis carinii infections.
    DOI:
    10.1021/jm00053a007
  • 作为产物:
    描述:
    potassium 4-(3-cyanophenyl)-2-mercaptopyrimidine 在 sodium hydroxide间氯过氧苯甲酸 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 26.5h, 生成 4-(3-cyanophenyl)-2-cyanopyrimidine
    参考文献:
    名称:
    S-Adenosylmethionine decarboxylase inhibitors: new aryl and heteroaryl analogs of methylglyoxal bis(guanylhydrazone)
    摘要:
    A series of 3-acylbenzamidine (amidino)hydrazones 7a-h, the corresponding (hetero)aromatic congeners 7i-p, and 3,3'-bis-amidino-biaryls 25a-e were synthesized. The hydrazones 7a-p were prepared by conversion of the corresponding acyl nitriles 1a,c-di,n-p to the imido esters 3a,c-d,i and the amidines 5a,c-d,h-i, followed by a reaction with aminoguanidine, or vice versa. Similarly, the biaryl 3,3'-dinitriles 23a-e were converted, via the imino esters 24a-c or the imino thioesters 27d-e, to the diamidines 25a-e. These new products are conformationally constrained analogues of methylglyoxal bis(guanylhydrazone)(MGBG). They are up to 100 times more potent as inhibitors of rat liver S-adenosylmethionine decarboxylase (SAMDC) and generally low potent inhibitors of rat small intestine diamine oxidase (DAO) than MGBG. Some of these SAMDC inhibitors, eg., compounds 7a, 7e, 7i, 25a, and 25d, have shown antiproliferative effects against T24 human bladder carcinoma cells. These products, whose structure-activity relationships are discussed, are of interest as potential anticancer agents and drugs for the treatment of protozoal and Pneumocystis carinii infections.
    DOI:
    10.1021/jm00053a007
点击查看最新优质反应信息

文献信息

  • Bipyridine compounds
    申请人:Ciba-Geigy Corporation
    公开号:US04968804A1
    公开(公告)日:1990-11-06
    Compounds of formula I ##STR1## wherein X.sub.1, X.sub.2, X.sub.3, X.sub.4, X.sub.5, X.sub.6, Y, Z and R.sub.1 -R.sub.4 are as defined in the description, have valuable pharmaceutical properties and are especially active against tumours. They are prepared in a manner known per se.
    式I的化合物,其中X.sub.1,X.sub.2,X.sub.3,X.sub.4,X.sub.5,X.sub.6,Y,Z和R.sub.1 -R.sub.4如描述中所定义,具有有价值的药物性质,特别对抗肿瘤活性强。它们以已知的方式制备。
  • Biaryl compounds
    申请人:Ciba-Geigy Corporation
    公开号:US05064832A1
    公开(公告)日:1991-11-12
    Compounds of formula I ##STR1## wherein X.sub.1, X.sub.2, X.sub.3, X.sub.4, X.sub.5, X.sub.6, Y, Z and R.sub.1 -R.sub.4 are as defined in the description, have valuable pharmaceutical properties and are especially active against tumors. They are prepared in a manner known per se.
    公式为I的化合物,其中X.sub.1,X.sub.2,X.sub.3,X.sub.4,X.sub.5,X.sub.6,Y,Z和R.sub.1-R.sub.4的定义如描述中所述,具有有价值的药物特性,特别是对肿瘤具有高活性。它们以已知的方式制备。
  • Biarylverbindungen
    申请人:CIBA-GEIGY AG
    公开号:EP0350448A1
    公开(公告)日:1990-01-10
    Verbindungen der Formel I worin X₁, X₂, X₃, X₄, X₅, X₆, Y, Z und R₁-R₄ die in der Beschreibung angegebenen Bedeutungen haben, weisen wertvolle pharmazeutische Eigenschaften auf und sind insbesondere gegen Tumoren wirksam. Sie werden in an sich bekannter Weise hergestellt.
    式 I 的化合物 其中 X₁、X₂、X₃、X₄、X₅、X₆、Y、Z 和 R₁-R₄ 具有说明中给出的含义,具有重要的药用特性,对肿瘤特别有效。它们以已知的方式生产。
  • US4968804A
    申请人:——
    公开号:US4968804A
    公开(公告)日:1990-11-06
  • US5064832A
    申请人:——
    公开号:US5064832A
    公开(公告)日:1991-11-12
查看更多